![Kristen McIntosh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kristen McIntosh
Directeur des opérations chez Blackrock Microsystems, Inc.
Postes actifs de Kristen McIntosh
Sociétés | Poste | Début | Fin |
---|---|---|---|
Blackrock Microsystems, Inc.
![]() Blackrock Microsystems, Inc. Packaged SoftwareTechnology Services Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then. | Directeur des opérations | - | - |
Historique de carrière de Kristen McIntosh
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Operating Officer | 1 |
Sectorielle
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Blackrock Microsystems, Inc.
![]() Blackrock Microsystems, Inc. Packaged SoftwareTechnology Services Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then. | Technology Services |
- Bourse
- Insiders
- Kristen McIntosh
- Expérience